ConductScience.org, home

Paper35924232

A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.

Xu HH and 3 others. Front Immunol, 2022. Cited by 23 papers, by iCite.

Cite this record

ConductScience Library. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes. Papers, record 35924232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35924232

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
PubMed
Journal
Front Immunol
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
1.68
iCite
Revised in PubMed
2025-10-31
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Xu HHHui-Hui
2Wang HLHui-Li
3Xing TJTong-Jin
4Wang XQXue-Quan

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Squamous CellMajor topic
Uterine Cervical NeoplasmsMajor topic
Biomarkers, Tumor
Female
HLA-G Antigens
Humans
Prognosis
Tumor Microenvironment

Source PubMed

Download CSV of topics

References60

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132699524SUV39H1-DNMT3A-mediated epigenetic regulation of Tim-3 and galectin-9 in the cervical cancer.Cancer Cell Int2020https://conductscience.org/library/papers/32699524PubMed
227997895Lower Expression of SPRY4 Predicts a Poor Prognosis and Regulates Cell Proliferation in Colorectal Cancer.Cell Physiol Biochem2016https://conductscience.org/library/papers/27997895PubMed
330531897Dimensionality reduction for visualizing single-cell data using UMAP.Nat Biotechnol2018https://conductscience.org/library/papers/30531897PubMed
428932645Intratumor heterogeneity of immune checkpoints in primary renal cell cancer: Focus on HLA-G/ILT2/ILT4.Oncoimmunology2017https://conductscience.org/library/papers/28932645PubMed
531164885The Role of Membrane Bound Complement Regulatory Proteins in Tumor Development and Cancer Immunotherapy.Front Immunol2019https://conductscience.org/library/papers/31164885PubMed
625450584The role of signaling pathways in cervical cancer and molecular therapeutic targets.Arch Med Res2014https://conductscience.org/library/papers/25450584PubMed
732495519Expression of classical human leukocyte antigen class I antigens, HLA-E and HLA-G, is adversely prognostic in pancreatic cancer patients.Cancer Sci2020https://conductscience.org/library/papers/32495519PubMed
833160404Identification of an autophagy-related gene signature for survival prediction in patients with cervical cancer.J Ovarian Res2020https://conductscience.org/library/papers/33160404PubMed
932104259ERK/MAPK signalling pathway and tumorigenesis.Exp Ther Med2020https://conductscience.org/library/papers/32104259PubMed
1030207593Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2018https://conductscience.org/library/papers/30207593PubMed
1121204120Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers.Stat Med2011https://conductscience.org/library/papers/21204120PubMed
1229066539TCR-stimulated changes in cell surface CD46 expression generate type 1 regulatory T cells.Sci Signal2017https://conductscience.org/library/papers/29066539PubMed
1334249930Identification of an Metabolic Related Risk Signature Predicts Prognosis in Cervical Cancer and Correlates With Immune Infiltration.Front Cell Dev Biol2021https://conductscience.org/library/papers/34249930PubMed
1417846022HLA-G expression in human ovarian carcinoma counteracts NK cell function.Ann Oncol2007https://conductscience.org/library/papers/17846022PubMed
1531693397Extracellular vesicles as biomarkers and therapeutic targets for cancer.Am J Physiol Cell Physiol2020https://conductscience.org/library/papers/31693397PubMed
1617569110Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.Stat Med2008https://conductscience.org/library/papers/17569110PubMed
1727659144Perilipin 2 and Age-Related Metabolic Diseases: A New Perspective.Trends Endocrinol Metab2016https://conductscience.org/library/papers/27659144PubMed
1821299526Up-regulation of HLA-G expression in cervical premalignant and malignant lesions.Tissue Antigens2011https://conductscience.org/library/papers/21299526PubMed
1932630545HLA-G: A New Immune Checkpoint in Cancer?Int J Mol Sci2020https://conductscience.org/library/papers/32630545PubMed
2027642559Upregulation of long noncoding RNA SPRY4-IT1 correlates with tumor progression and poor prognosis in cervical cancer.FEBS Open Bio2016https://conductscience.org/library/papers/27642559PubMed

See all 60 referencesDownload CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
42798542Prognostic impact of HLA-G expression in cervical squamous cell carcinoma: correlation with PD-L1 and CD8-positive tumor infiltrating lymphocytes.Front Immunol2026https://conductscience.org/library/papers/42798542PubMed
42724752A three-gene radioresistance signature predicts tumor progression in cervical cancer.Transl Cancer Res2026https://conductscience.org/library/papers/42724752PubMed
42180867A novel programmed-cell-death-related prognostic risk model for cervical cancer based on mitochondrial genes.Transl Cancer Res2026https://conductscience.org/library/papers/42180867PubMed
42100295CERV-Score: A Hybrid Machine Learning Framework for Cervical Cancer Risk Prediction Using Integrated Clinical and Genomic Data.Int J Telemed Appl2026https://conductscience.org/library/papers/42100295PubMed
41821896The critical role of ferroptosis in thyroid cancer development and potential therapeutic implications.Front Oncol2026https://conductscience.org/library/papers/41821896PubMed
40747615Development of a Mitochondrial Permeability Transition-Driven Necrosis-Related Prognostic Signature in Cervical Cancer: Integrating Bulk Transcriptomic and Single-Cell Data.Cancer Med2025https://conductscience.org/library/papers/40747615PubMed
39994715Prognostic assessment of cervical cancer based on biomarkers: the interaction of ERRα and immune microenvironment.Virol J2025https://conductscience.org/library/papers/39994715PubMed
39950465miR-584-5p Regulates MSMO1 to Modulate the AKT/PI3K Pathway and Inhibit Breast Cancer Progression.Protein Pept Lett2025https://conductscience.org/library/papers/39950465PubMed
39525016Up-regulation of MSMO1 was associated with poor survival in cervical cancer.Transl Cancer Res2024https://conductscience.org/library/papers/39525016PubMed
39469714HLA-G expression associates with immune evasion muscle-invasive urothelial cancer and drives prognostic relevance.Front Immunol2024https://conductscience.org/library/papers/39469714PubMed
38919630The complement regulatory protein CD46 serves as a novel biomarker for cervical cancer diagnosis and prognosis evaluation.Front Immunol2024https://conductscience.org/library/papers/38919630PubMed
38655053LINC01614 is a promising diagnostic and prognostic marker in HNSC linked to the tumor microenvironment and oncogenic function.Front Genet2024https://conductscience.org/library/papers/38655053PubMed
38310272Harnessing the potential of HLA-G in cancer therapy: advances, challenges, and prospects.J Transl Med2024https://conductscience.org/library/papers/38310272PubMed
37623251HLA-G 14 bp Ins/Del (rs66554220) Variant Is Not Associated with Breast Cancer in Women from Western Mexico.Curr Issues Mol Biol2023https://conductscience.org/library/papers/37623251PubMed
37510286Prediction of Prognosis and Chemotherapeutic Sensitivity Based on Cuproptosis-Associated lncRNAs in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.Genes (Basel)2023https://conductscience.org/library/papers/37510286PubMed
36846109Immunosuppression by Inflammation-Stimulated Amplification of Myeloid-Derived Suppressor Cells and Changes in Expression of Immune Checkpoint HHLA2 in Chronic Obstructive Pulmonary Disease.Int J Chron Obstruct Pulmon Dis2023https://conductscience.org/library/papers/36846109PubMed
36685946Identification of a tissue resident memory CD8 T cell-related risk score signature for colorectal cancer, the association with TME landscapes and therapeutic responses.Front Genet2022https://conductscience.org/library/papers/36685946PubMed
36406134A panel of seven immune-related genes can serve as a good predictive biomarker for cervical squamous cell carcinoma.Front Genet2022https://conductscience.org/library/papers/36406134PubMed

Download CSV of cited by

Genes39

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APC324PubTator's text mininghttps://conductscience.org/library/genes/324NCBI Gene
APOC1341PubTator's text mininghttps://conductscience.org/library/genes/341NCBI Gene
CACNB3784PubTator's text mininghttps://conductscience.org/library/genes/784NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD464179PubTator's text mininghttps://conductscience.org/library/genes/4179NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
CXCL83576PubTator's text mininghttps://conductscience.org/library/genes/3576NCBI Gene
DAGLB221955PubTator's text mininghttps://conductscience.org/library/genes/221955NCBI Gene
DNMT3A1788PubTator's text mininghttps://conductscience.org/library/genes/1788NCBI Gene
DSG21829PubTator's text mininghttps://conductscience.org/library/genes/1829NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
ERBB32065PubTator's text mininghttps://conductscience.org/library/genes/2065NCBI Gene
GLTP51228PubTator's text mininghttps://conductscience.org/library/genes/51228NCBI Gene
HAVCR284868PubTator's text mininghttps://conductscience.org/library/genes/84868NCBI Gene
HLA-A3105PubTator's text mininghttps://conductscience.org/library/genes/3105NCBI Gene
HLA-G3135PubTator's text mininghttps://conductscience.org/library/genes/3135NCBI Gene
HLTF6596PubTator's text mininghttps://conductscience.org/library/genes/6596NCBI Gene

See all 39 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35924232

GET https://conductscience.org/api/papers/v1/35924232/references?page=2